{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:20:19Z","timestamp":1791127219241,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,31]],"date-time":"2014-10-31T00:00:00Z","timestamp":1414713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00415-014-7552-z","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T05:20:48Z","timestamp":1414646448000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study"],"prefix":"10.1007","volume":"262","author":[{"given":"Alexander","family":"Tinchon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Oberndorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Marosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gleiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Geroldinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Sax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camillo","family":"Sherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Grisold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,31]]},"reference":[{"key":"7552_CR1","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-59259-317-0","volume-title":"Cancer neurology in clinical practice","author":"D Schiff","year":"2003","unstructured":"Schiff D, Wen P (2003) Cancer neurology in clinical practice. Humana Press Inc., Germany"},{"issue":"Suppl. 9","key":"7552_CR2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/epi.12437","volume":"54","author":"M Kerkhof","year":"2013","unstructured":"Kerkhof M, Vecht CJ (2013) Seizure characteristics and prognostic factors of gliomas. Epilepsia 54(Suppl. 9):12\u201317","journal-title":"Epilepsia"},{"issue":"5","key":"7552_CR3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/era.10.48","volume":"10","author":"CJ Vecht","year":"2010","unstructured":"Vecht CJ, Wilms EB (2010) Seizures in low- and high-grade gliomas: current management and future outlook. Expert Rev Anticancer Ther 10(5):663\u2013669","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"7552_CR4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11060-010-0126-8","volume":"99","author":"JB Usery","year":"2010","unstructured":"Usery JB, Michael LM 2nd, Sills AK, Finch CK (2010) A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures. J Neurooncol 99(2):251\u2013260","journal-title":"J Neurooncol"},{"issue":"6","key":"7552_CR5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/CCO.0b013e32833de99d","volume":"22","author":"R Rud\u00e0","year":"2010","unstructured":"Rud\u00e0 R, Trevisan E, Soffietti R (2010) Epilepsy and brain tumors. Curr Opin Oncol 22(6):611\u2013620","journal-title":"Curr Opin Oncol"},{"issue":"7\u20138","key":"7552_CR6","first-page":"444","volume":"36","author":"C Scaringi","year":"2013","unstructured":"Scaringi C, De Sanctis V, Minniti G, Enrici RM (2013) Temozolomide-related hematologic toxicity. Onkologie 36(7\u20138):444\u2013449","journal-title":"Onkologie"},{"issue":"10","key":"7552_CR7","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/CAD.0b013e328356f5b0","volume":"23","author":"S Dixit","year":"2012","unstructured":"Dixit S, Baker L, Walmsley V, Hingorani M (2012) Temozolomide-related idiosyncratic and other uncommon toxicities: a systematic review. Anticancer Drugs 23(10):1099\u20131106","journal-title":"Anticancer Drugs"},{"issue":"1","key":"7552_CR8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00280-011-1679-8","volume":"69","author":"JL Villano","year":"2012","unstructured":"Villano JL, Letarte N, Yu JM, Abdur S, Bressler LR (2012) Hematologic adverse events associated with temozolomide. Cancer Chemother Pharmacol 69(1):107\u2013113","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"7552_CR9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1215\/15228517-2006-024","volume":"9","author":"DE Gerber","year":"2007","unstructured":"Gerber DE, Grossman SA, Zeltzman M, Parisi MA, Kleinberg L (2007) The impact on thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas. Neuro Oncol 9(1):47\u201352","journal-title":"Neuro Oncol"},{"issue":"2","key":"7552_CR10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11060-007-9403-6","volume":"85","author":"N Singhal","year":"2007","unstructured":"Singhal N, Selva-Nayagam S, Brown MP (2007) Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment\u2014case study and review of literature. J Neurooncol 85(2):229\u2013300","journal-title":"J Neurooncol"},{"issue":"1","key":"7552_CR11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11060-007-9398-z","volume":"85","author":"R Jalalj","year":"2007","unstructured":"Jalalj R, Singh P, Menon H, Guiral S (2007) Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide. J Neurooncol 85(1):105\u2013107","journal-title":"J Neurooncol"},{"issue":"12","key":"7552_CR12","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","volume":"77","author":"M Weller","year":"2011","unstructured":"Weller M, Gorlia T, Cairncross JG et al (2011) Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma. Neurology 77(12):1156\u20131164","journal-title":"Neurology"},{"issue":"7","key":"7552_CR13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/neuonc\/not057","volume":"15","author":"M Kerkhof","year":"2013","unstructured":"Kerkhof M, Dielemans JC, van Breemen MS et al (2013) Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro Oncol 15(7):961\u2013967","journal-title":"Neuro Oncol"},{"issue":"3","key":"7552_CR14","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijrobp.2013.02.012","volume":"86","author":"CA Barker","year":"2013","unstructured":"Barker CA, Bishop AJ, Chang M, Beal K, Chan TA (2013) Valproic acid use during radiation therapy for glioblastoma associated with improved survival. Int J Radiat Oncol Biol Phys 86(3):504\u2013509","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"7552_CR15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","volume":"72","author":"S Oberndorfer","year":"2005","unstructured":"Oberndorfer S, Piribauer M, Marosi C, Lahrmann H, Hitzenberger P, Grisold W (2005) P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy. J Neurooncol 72(3):255\u2013260","journal-title":"J Neurooncol"},{"issue":"10","key":"7552_CR16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987\u2013996","journal-title":"N Engl J Med"},{"issue":"1","key":"7552_CR17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00043426-200001000-00012","volume":"22","author":"S Acharya","year":"2000","unstructured":"Acharya S, Bussel JB (2000) Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol 22(1):62\u201365","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"7552_CR18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","volume":"49","author":"W Nasreddine","year":"2008","unstructured":"Nasreddine W, Beydoun A (2008) Valproate-induced thrombocytopenia: a prospective monotherapy study. Epilepsia 49(3):438\u2013445","journal-title":"Epilepsia"},{"issue":"7","key":"7552_CR19","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1528-1167.2006.00596.x","volume":"47","author":"KB Handoko","year":"2006","unstructured":"Handoko KB, Souverein PC, van Staa TP et al (2006) Risk of aplastic anemia in patients using antiepileptic drugs. Epilepsia 47(7):1232\u20131236","journal-title":"Epilepsia"},{"issue":"11","key":"7552_CR20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2165\/11319450-000000000-00000","volume":"29","author":"M Gallerani","year":"2009","unstructured":"Gallerani M, Mari E, Boari B, Carletti R, Marra A, Cavallo M (2009) Pancytopenia associated with levetiracetam treatment. Clin Drug Investig 29(11):747\u2013751","journal-title":"Clin Drug Investig"},{"issue":"12","key":"7552_CR21","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1111\/j.1528-1167.2010.02788.x","volume":"51","author":"K Sahaya","year":"2010","unstructured":"Sahaya K, Goyal MK, Sarwal A, Singh NN (2010) Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study. Epilepsia 51(12):2492\u20132495","journal-title":"Epilepsia"},{"issue":"1","key":"7552_CR22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.eplepsyres.2008.03.002","volume":"80","author":"A Meschede","year":"2008","unstructured":"Meschede A, Runge U, Sabolek M (2008) Thrombocytopenia during levetiracteam therapy. Epilepsy Res 80(1):91\u201392","journal-title":"Epilepsy Res"},{"issue":"9","key":"7552_CR23","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00415-009-5156-9","volume":"256","author":"MS Breemen van","year":"2009","unstructured":"van Breemen MS, Rijsman RM, Taphoorn MJ, Walchenbach R, Zwinkels H, Vecht CJ (2009) Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 256(9):1519\u20131526","journal-title":"J Neurol"},{"issue":"7","key":"7552_CR24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1634\/theoncologist.2014-0060","volume":"19","author":"CJ Vecht","year":"2014","unstructured":"Vecht CJ, Kerkhof M, Duran-Pena A (2014) Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist 19(7):751\u2013759","journal-title":"Oncologist"},{"issue":"Suppl 9","key":"7552_CR25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/epi.12452","volume":"54","author":"E Perucca","year":"2013","unstructured":"Perucca E (2013) Optimizing antiepileptic drug treatment in tumoral epilepsy. Epilepsia 54(Suppl 9):97\u2013104","journal-title":"Epilepsia"},{"key":"7552_CR26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fneur.2013.00153","volume":"4","author":"E Fonkem","year":"2013","unstructured":"Fonkem E, Bricker P, Mungall D, Aceves J, Ebwe E, Tang W, Kirmani B (2013) The role of levetiracetam in treatment of seizures in brain tumor patients. Front Neurol 4:153","journal-title":"Front Neurol"},{"issue":"9","key":"7552_CR27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s40263-013-0094-6","volume":"27","author":"YJ Lee","year":"2013","unstructured":"Lee YJ, Kim T, Bae SH et al (2013) Levetiracetam compared with valproic acid for the prevention of postoperative seizures after supratentorial tumor surgery: a retrospective chart review. CNS Drugs 27(9):753\u2013759","journal-title":"CNS Drugs"},{"issue":"4","key":"7552_CR28","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1200\/JCO.2004.07.060","volume":"22","author":"YB Su","year":"2004","unstructured":"Su YB, Sohn S, Krown SE et al (2004) Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J Clin Oncol 22(4):610\u2013616","journal-title":"J Clin Oncol"},{"issue":"2","key":"7552_CR29","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.onc.1207080","volume":"23","author":"W Roos","year":"2004","unstructured":"Roos W, Baumgartner M, Kaina B (2004) Apoptosis triggered by DNA damage 06-methylguanine in human lymphocytes requires DNA replication and is mediated by p53 and Fas\/CD95\/Apo-1. Oncogene 23(2):359\u2013367","journal-title":"Oncogene"},{"issue":"1","key":"7552_CR30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/1097-0142(197801)41:1<108::AID-CNCR2820410116>3.0.CO;2-Z","volume":"41","author":"IC MacLennan","year":"1978","unstructured":"MacLennan IC, Kay HE (1978) Analysis of treatment in childhood leukemia. IV. The critical association between dose fractionation and immunosuppression induced by cranial irradiation. Cancer 41(1):108\u2013111","journal-title":"Cancer"},{"issue":"3","key":"7552_CR31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2307\/3573724","volume":"56","author":"E Weeke","year":"1973","unstructured":"Weeke E (1973) The development of lymphopenia in uremic patients undergoing extracorporeal irradiation of the blood with portable beta units. Radiat Res 56(3):554\u2013559","journal-title":"Radiat Res"},{"issue":"2","key":"7552_CR32","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/07357907.2012.762780","volume":"31","author":"S Yovino","year":"2013","unstructured":"Yovino S, Kleinberg L, Grossman SA, Narayanan M, Ford E (2013) The etiology of treatment-related lymphopenia in patients with malignant gliomas: modelling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells. Cancer Invest 31(2):140\u2013144","journal-title":"Cancer Invest"},{"issue":"2","key":"7552_CR33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/cns.12.14","volume":"1","author":"S Yovino","year":"2012","unstructured":"Yovino S, Grossman SA (2012) Severity, etiology and possible consequences of treatment-related lymphopenia in patients with newly diagnosed high-grade gliomas. CNS Oncol 1(2):149\u2013154","journal-title":"CNS Oncol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7552-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-014-7552-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-014-7552-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:22:45Z","timestamp":1559071365000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-014-7552-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,31]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["7552"],"URL":"https:\/\/doi.org\/10.1007\/s00415-014-7552-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,31]]}}}